Skip to content

Ferrous Phosphate

  • Plant preparation
  • Varies by country
  • Identity checked
  • Sources last checked 2026-09-04

This page shows what was measured, who it was measured in, and what that does not settle.

What Ferrous Phosphate does in the body

RNAWiki has not recorded what this substance changes in the body.

What happened in people

RNAWiki has not yet published a reviewed conclusion for this use.

A fixed RNAWiki sentence

Where this came from

Wording RNAWiki always uses, not a finding about this substance.

No reviewed claim names a result for any goal on this record.

No source is stored against this line.

The limit that matters most

Not recorded.

Where it acts
Not recorded.
Kind of result
No result is published, so no kind of result applies yet
Supervision
Not usually supervised: sold as a supplement or food ingredient where recorded. That is a legal category, not a safety judgement.

What the registries record it as

  • The substance registry classes this as chemical.

    FDA substance registry · D07L04MRWI · read 2026-08-29

  • The supplement label database classes it as mineral, under the name Iron.

    NIH Dietary Supplement Label Database · 254 · read 2026-08-29

Where each sentence above came from

No plain explanation of what this changes is stored.

No recorded use is stored in reader language.

No statement of the main limit is recorded.

The four opening statements run to 26 words.

Words this page uses

Four words worth knowing first

Chosen from what this page shows, with each one explained before the word it depends on.

Biomarker

A biomarker is a number from a test that stands in for something about health.

A picture of it, and where the picture fails

A biomarker is like a fuel gauge.

Where that stops being true. A gauge is wired to the tank. Many biomarkers are only loosely tied to health.

What people get wrong. A better number is read as a better life. Several medicines improved a number and helped nobody.

A measurable indicator used as a substitute for a clinical outcome of interest.

Placebo

A placebo is a dummy treatment given so the real one can be compared with it.

A picture of it, and where the picture fails

A placebo is like a blank control in an experiment.

Where that stops being true. A blank does nothing. People given a placebo often do get better.

What people get wrong. A placebo effect is read as imaginary. The improvement is measured and real.

An inactive intervention matched in appearance to the test intervention, used to control for non-specific effects.

Comparator

A comparator is whatever the treatment was measured against.

A picture of it, and where the picture fails

It is like the other runner in a race.

Where that stops being true. A race has one winner. A study can show both arms improved.

What people get wrong. Results are read without asking what the other group got. Beating nothing is not beating a treatment.

The control condition against which the experimental intervention is assessed.

What happened in peopleRead from sources, not yet reviewed

What happened in people

Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.

Changes in mean hemoglobin concentrations

The study did not show it

Who was studied
NCT02567981
How many people
4577
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot
  • ClinicalTrials.gov · a recorded source, not a stored snapshot

Composite outcome

The study did not show it

Who was studied
NCT05060731
How many people
570
Study design
Phase 4
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot
  • ClinicalTrials.gov · a recorded source, not a stored snapshot

Proportion of patients who achieve normalized Hb-levels or increased Hb of at least 1.5 g/dl

The study did not show it

Who was studied
NCT03817957
How many people
187
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot
  • ClinicalTrials.gov · a recorded source, not a stored snapshot

Lipid peroxidation Malondialdehyde (MDA)

The study did not show it

Who was studied
NCT03740295
How many people
60
Study design
Phase 2
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot
  • ClinicalTrials.gov · a recorded source, not a stored snapshot

fractional iron absorption

The study did not show it

Who was studied
NCT03762148
How many people
46
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot
  • ClinicalTrials.gov · a recorded source, not a stored snapshot

Determination of iron absorption from FAP and from ferric pyrophosphate relative to Ferrous sulfate

The study did not show it

Who was studied
NCT05642689
How many people
40
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route.

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA Drugs@FDA · a recorded source, not a stored snapshot
  • Europe PMC · a recorded source, not a stored snapshot
  • ClinicalTrials.gov · a recorded source, not a stored snapshot
What we know
RNAWiki holds 6 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.

What is missing or unclearRead from sources, not yet reviewed

Were people like you studied?

RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.

Who was studied

No description of who was studied is recorded.

Who is missing from the studies

  • Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

Where the result stopped carrying

  • This is a scope explorer, not a diagnosis engine.
  • It shows who was studied so you can see whether people similar to you were included.

RNAWiki cannot tell whether a study fits you. It can show who was in it.

What it would be like to takeRead from sources, not yet reviewed

Why it might seem to do nothing

A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.

It was studied in different people

The people in the studies were not much like the reader.

On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

The evidence may simply be wrong

Small early studies often do not hold up.

On this record: RNAWiki has not yet published a reviewed conclusion for this use.

Other reasons RNAWiki checked and found nothing for (11)
It was studied for a different goal
The studies measured something else entirely. Nothing in this record points to this reason.
A different form was studied
The studied form is not the form on the shelf. Nothing in this record points to this reason.
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
Something else had to happen too
In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
The product may not be what it says
Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.

None of these is a reason to take more. Taking more is not a step this page ever suggests.

What it would be like to takeRead from sources, not yet reviewed

What taking it involves

The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.

How it is supplied

Varies by country

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Read from the recorded approval status.

No source is stored against this line.

Form and route

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No form or route is recorded.

No source is stored against this line.

Who oversees it

Not usually supervised: sold as a supplement or food ingredient where recorded. That is a legal category, not a safety judgement.

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

The identity record classes it as a supplement ingredient; no medicines register records an approval.

No source is stored against this line.

What is in the pack

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing is recorded about product quality.

No source is stored against this line.

Where it is registered

Regulatory records are listed in the technical disclosure at the foot of this page.

Counted from records

Where this came from

A count of rows RNAWiki holds. It describes our records, not your body.

Register entries are stored per jurisdiction and shown with their dates.

No source is stored against this line.

Why people stop

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No record of why people stopped taking it is stored for this substance.

No source is stored against this line.

What it would be like to takeNothing found in the sources checked

What can go wrong

Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.

Nothing found in the sources checked

No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.

The sources listed were searched and held nothing. That is not the same as nothing existing.

Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.

Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What is missing or unclearRead from sources, not yet reviewed

Does the exact form matter?

Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.

The form that was studied

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

The exact form studied is not recorded.

No source is stored against this line.

What is sold

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing further is recorded about which forms are sold.

No source is stored against this line.

What is recorded as being sold

  • 66 published labels name it as an active ingredient. 7 of them describe this substance alone, which is where its own label text on this page comes from.

    US prescribing information · 597caf33-5107-9dec-e063-6294a90a5fcd · read 2026-08-29

  • Those labels are classed as human otc drug and human prescription drug.

    US prescribing information · 597caf33-5107-9dec-e063-6294a90a5fcd · read 2026-08-29

  • 4270 marketed supplement labels list this ingredient, classed as mineral.

    NIH Dietary Supplement Label Database · 176567 · read 2026-08-29

  • Those labels carry all other, nutrient and structure/function claims. A claim of that kind is written by the manufacturer and is not assessed by any regulator, so its presence says nothing about whether it is true.

    NIH Dietary Supplement Label Database · 176567 · read 2026-08-29

Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.

What it would be like to takeRead from sources, not yet reviewed

What you could measure

Watching one thing carefully can tell you whether it moved. It cannot tell you what moved it.

This is sold without a prescription, so a person can sensibly watch one thing and see whether it moves.

  1. Pick one goal. One goal only. Two at once cannot be told apart afterwards.

  2. Pick one thing to watch. No registered study lists a measure RNAWiki could read for this.

  3. Measure before you start. Take the same measurement several times first. One reading is not a starting point.

  4. Know the swing. Write down how much it moves on its own across a normal week.

  5. Change one thing. Change nothing else at the same time, including training and sleep.

  6. Give it the study length. No finished study window is recorded, so no length is suggested here.

  7. Track whether you took it. Missed days are the most common reason a home test shows nothing.

  8. Read the trend. Look at the line across weeks. A single reading tells you almost nothing.

What not to measure

  • Anything that swings more day to day than the change you are looking for.
  • A wearable estimate of sleep stages, which is an estimate and not a measurement.
  • Weight on one morning, which mostly records water.
  • A feeling you did not write down before starting.

When to stop

  • Stop if something new and unpleasant starts, and ask a pharmacist or doctor.
  • Stop if you cannot keep everything else steady, because the result will not mean anything.
  • Stop at the end of the window you set, and read the trend then.

Tracking can show whether something changed for you. It cannot show what caused it.

RNAWiki does not work out an amount for anyone.

What is missing or unclearRead from sources, not yet reviewed

What nobody knows yet

Open questions, each with why it is open and what would close it.

Missing populations

Which groups were under-represented in the studies has not been recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing long-term data

No completed tested study window is recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

No reviewed conclusion

RNAWiki has not yet published a reviewed conclusion for this use.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing interaction studies

No interaction was found in the registers checked. Not finding one is not the same as showing there is none.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Formulation uncertainty

Several salts, forms or products of Ferrous Phosphate are recorded. Results from one form may not transfer to another.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Mechanism not reviewed

No reviewed mechanism story exists for this substance.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

What happened in peopleRead from sources, not yet reviewed

Check any of this yourself

Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.

Where else this substance is registered

FDA substance identifier (UNII)
D07L04MRWI
CAS registry number
14940-41-1
PubChem compound
9863567
RxNorm concept
107056
EMA substance identifier
100000078452
European Chemicals Agency number
239-018-0

Checks this page had to pass

  • Passed

    Identity resolved

    no open identity hold

  • Passed

    No unresolved merge across substance families

    no quarantine open

  • Not passed

    Every public sentence names a source

    The opening statement carries no source: the record holds neither an explanation nor a recorded use.

  • Not passed

    Trial roles classified for highlighted evidence

    No registered study is classified as testing this substance.

  • Passed

    No internal keys in reader text

    enforced by the copy-contract test over the rendered page

  • Passed

    Safety mode resolved

    The identity record classes it as a supplement ingredient; no medicines register records an approval.

  • Passed

    Canonical metadata present

    slug and display name present

What is missing or unclearRead from sources, not yet reviewed

What to learn next

Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.

This order is fixed in code and does not count clicks or time on the page.

What is not here

10 questions this page could not answer

These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.

  • What was measured, goal by goal — found nothing in the sources checked.
  • How close this is to real life — found nothing in the sources checked.
  • The path through the body — found nothing in the sources checked.
  • Felt, measured, or meaningful — found nothing in the sources checked.
  • How long anything takes — found nothing in the sources checked.
  • What it may clash with — found nothing in the sources checked.
  • Other ways to the same goal — found nothing in the sources checked.
  • Claims that go past the evidence — found nothing in the sources checked.
  • How this medicine reached us — found nothing in the sources checked.
  • What changed on this page — found nothing in the sources checked.

The record as stored

The full record, for auditing

Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.

Recorded evidence blocks (6)

On the Ferrous Phosphate label: indicated for what?


"Helps temporarily relieve: occasional poor appetite; feelings of tiredness or weakness; congestion; aches; elevated body temperature; and headaches.": indications and usage on Ferrous Phosphate's label. DailyMed label · 53ba97b3-db1d-6d8a-e063-6394a90aa8f1 · 2026-06-08

175 registered trials of Ferrous Phosphate — at which phases?


Registered studies posting no result
136 of 175

175 registered studies of Ferrous Phosphate: 64 na, 42 phase3, 42 phase4, 18 phase2, 5 early phase1, 5 phase1, 3 na or unstated. CLINICALTRIALS_SNAPSHOT · 2026-09-01

0 with a PubMed record

Show the evidence
  • na
    64
  • phase3
    42
  • phase4
    42
  • phase2
    18
  • early phase1
    5
  • phase1
    5
7 more recorded rows
  • na or unstated
    3
  • completed
    114
  • unknown
    20
  • recruiting
    13
  • terminated
    13
  • not yet recruiting
    8
  • withdrawn
    7

recorded 2026-09-01 · last checked 2026-09-04

20 of Ferrous Phosphate's trials stopped: safety, accrual/recruitment, funding/business, other?


safety (2), accrual/recruitment (8), funding/business (4) and other (6): Ferrous Phosphate's stop wording, clustered. CLINICALTRIALS_SNAPSHOT · 2026-09-01

"The study was terminated because of significant enrollment challenges"; 20 of 175 registered studies

Show the evidence

Trial

  • NCT00223938
    terminated; "The study was terminated because of significant enrollment challenges"
  • NCT00830037
    terminated; "Terminated by the DSMB based on low chance of finding differences in mGFR slopes, but higher risk of serious adverse events in the IV iron group (aIRR = 1.60)"
  • NCT00929409
    terminated; "Stopped prematurely because too few patients were recruited."
  • NCT00999479
    withdrawn; "Poor enrollment"
  • NCT01155375
    terminated; "Several factors contributed to significant challenges in enrollment and led the Sponsor to discontinue the AMAG-FER-CKD-251 study as designed."
  • NCT01155388
    terminated; "Several factors contributed to significant challenges in enrollment and led the Sponsor to discontinue the AMAG-FER-CKD-252 study as designed."
14 further recorded trials
  • NCT01438372
    withdrawn; "The study was terminated prior to enrolling patients as we were unable to secure enough funding to complete the study."
  • NCT01656434
    terminated; "Business reasons"
  • NCT01837030
    withdrawn; "not feasible due to funding"
  • NCT01865175
    withdrawn; "Institution required IND, although FDA did not, so institution did not allow enrollment"
  • NCT01908543
    terminated; "Technical issues with availability of relevant personnel"
  • NCT01975272
    terminated; "Disapointing randomization rate"
  • NCT02825719
    terminated; "Ulipristal was withdrawal from the market"
  • NCT02839096
    terminated; "Lack of funds, PI left University"
  • NCT03777514
    withdrawn; "Study wasn't started."
  • NCT04087993
    withdrawn; "difficult recruitment - redesign in discussion"
  • NCT04594070
    terminated; "Unable to recruit enough participants"
  • NCT04610827
    terminated; "Change in personnel and lack of resources to continue."
  • NCT05152641
    withdrawn; "The program priority for execution of this clinical trial changed prior to enrollment of the first patient. The study was not withdrawn due to any safety concerns."
  • NCT07053475
    terminated; "Post-discharge low follow-up (\<50%) rates."

recorded 2026-09-01 · last checked 2026-09-04

Human studies of Ferrous Phosphate used Upsher-Smith ferrous sulfate 325 mg tablets NDC# 00245-0108-11 — over how long?


Human studies of Ferrous Phosphate used "Upsher-Smith ferrous sulfate 325 mg tablets NDC# 00245-0108-11". ClinicalTrials.gov · 2026-09-01

20 recorded entries; human; oral; also "Ferrous sulfate 325mg", "Ferrous Fumarate 324 mg", "Ferrous sulphate 200mg oral tablet"

Show the evidence

human

  • NCT01438372
    Upsher-Smith ferrous sulfate 325 mg tablets NDC# 00245-0108-11
  • NCT01755455
    Ferrous sulfate 325mg
  • NCT01762995
    Ferrous Fumarate 324 mg
  • NCT01908543
    oral; Ferrous sulphate 200mg oral tablet
  • NCT02128971
    Ferrous fumarate 90 mg
  • NCT02128971
    Ferrous Sulfate 90 mg
14 more recorded rows
  • human NCT02300428
    Dried ferrous sulphate tablets 200mg
  • human NCT02300428
    Ferrous fumarate tablets 210mg
  • human NCT02300428
    Ferrous gluconate tablets 300mg
  • human NCT02300428
    Ferrous fumarate tablets 322mg (incl. Fersaday)
  • human NCT02300428
    Ferrous fumarate capsules 305mg (incl. Galfer)
  • human NCT02300428
    Dried ferrous sulphate MR tab 325mg (incl. Ferrograd)
  • human NCT03725384
    Ferrous Sulfate 300Mg Tablet
  • human NCT03762148
    ferrous fumarate + 3.5 g GOS
  • human NCT03762148
    ferrous fumarate + 7 g GOS
  • human NCT03762148
    ferrous sulphate + 15 g GOS
  • human NCT03762148
    ferrous fumarate + 7 g GOS + Vitamin C
  • human NCT04194255
    ferrous fumarate + 15 g GOS
  • human NCT04194255
    ferrous fumarate + 15 g FOS
  • human NCT04194255
    labelled iron as ferrous fumarate + 15 g acacia gum

recorded 2026-09-01 · last checked 2026-09-04

Which 76 trials of Ferrous Phosphate posted no result?


Posted no result
76 of 76 completed trials
Registrations
NCT04363905, NCT02346188, NCT00236964, NCT02146053, NCT00701246 and NCT00276224, and 70 more
Completion dates
oldest 2000-12-31; newest 2024-08-31
Show the evidence

Trial

  • NCT04363905
    2000-12-31
  • NCT02346188
    2001-12
  • NCT00236964
    2002-05-30
  • NCT02146053
    2004-12
  • NCT00701246
    2006-03
  • NCT00276224
    2006-04
14 further recorded trials
  • NCT00301054
    2006-04
  • NCT00841061
    2006-05
  • NCT00953134
    2008-03
  • NCT00867867
    2008-06
  • NCT00374790
    2008-07
  • NCT00364104
    2008-12
  • NCT01078818
    2009-05
  • NCT00919230
    2009-08
  • NCT01383798
    2009-12
  • NCT01991600
    2010-05
  • NCT01404533
    2011-12
  • NCT01216709
    2012-06
  • NCT01628770
    2012-12
  • NCT01762995
    2013-03

At the median, Ferrous Phosphate's trials enrolled 82 people — anything larger?


Median enrolment
82
Largest enrolment
406902
Registered trials counted
175
Where it is registered
Identifiers, relations and other names

The exact record

PubChem CID
9863567
CAS number
14940-41-1
RxCUI
107056
InChIKey
SDEKDNPYZOERBP-UHFFFAOYSA-H
Trade name
Schuessler Tissue Salts Ferr Phos First Aid 4
Salt form
FERRUM PHOSPHORICUM
Also called
FERROPHOSPHATE, FERROUS ORTHOPHOSPHATE, FERROUS PHOSPHATE [MI], Ferrous phosphate [WHO-DD], IRON PHOSPHATE (FE3(PO4)2), PHOSPHORIC ACID, IRON(2+) SALT (2:3)
Sources (4)

Sources

ClinicalTrials.gov — US Government work · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md · openFDA / DailyMed — US Government work

How these records are assembled · Which registers were checked

Index-quality checks
  • identity passed: no open identity hold
  • required summary fields resolved: 3 required field(s) not terminal: Best-supported result, Biggest unanswered question, Human evidence
  • public claims reviewed: 0 reviewed claim(s); drafts are never rendered
  • source coverage passed: 4 source rows
  • no critical contamination: no quarantine open
  • canonical metadata passed: slug and display name present
  • no raw internal fields: enforced by the copy-contract test over the rendered page

This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.